Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance)
- Citation:
- J Clin Oncol vol 33 (31) 3635-3640
- Year:
- 2015
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 5
- Parents:
- 810
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, CA33601, U10 CA031946, U10 CA033601, U10 CA180821, U10 CA180850, U10 CA180833, CA31946
- Corr. Author:
- Authors:
- John P. Leonard Sin-Ho Jung Jeffrey Johnson Brandelyn N. Pitcher Nancy L. Bartlett Kristie A. Blum Myron Czuczman Jeffrey K. Giguere Bruce D. Cheson
- Networks:
- CAPITAL, GREENVILLE, LAPS-MO011, LAPS-NY158, LAPS-OH007, NY018
- Study
- CALGB-50401
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Hema15, ORIGINAL REPORTS, Hematologic Malignancy